Diabetes Stocks List

Symbol Grade Name % Change
ALIM F Alimera Sciences, Inc. 0.83
ALKS B Alkermes plc 1.07
AMED F Amedisys Inc 1.25
ARNA B Arena Pharmaceuticals, Inc. 1.83
ATHX F Athersys, Inc. -1.34
CORT D Corcept Therapeutics Incorporated -0.58
DXCM A DexCom, Inc. -0.35
ESPR F Esperion Therapeutics, Inc. 3.31
GWPH A GW Pharmaceuticals Plc 0.00
HALO B Halozyme Therapeutics, Inc. -0.02
ICPT D Intercept Pharmaceuticals, Inc. 3.37
IONS D Ionis Pharmaceuticals, Inc. 2.14
LXRX C Lexicon Pharmaceuticals, Inc. 6.11
MNKD B MannKind Corporation -0.66
NBIX B Neurocrine Biosciences, Inc. 0.81
NURO D NeuroMetrix, Inc. 4.23
ORMP A Oramed Pharmaceuticals Inc. -1.77
PETS F PetMed Express, Inc. -2.08
PODD B Insulet Corporation 1.58
TRIB C Trinity Biotech plc -0.42
XOMA D XOMA Corporation 5.60
ABT A Abbott Laboratories -0.51
AMPE B Ampio Pharmaceuticals, Inc. 5.88
BDX A Becton, Dickinson and Company -0.27
BMY D Bristol-Myers Squibb Company 0.13
ENZ A Enzo Biochem, Inc. 4.32
LLY D Eli Lilly and Company -0.41
MRK F Merck & Company, Inc. -0.40
NVO A Novo Nordisk A/S -0.95
PRGO D Perrigo Company -0.77
OCUP C Ocuphire Pharma, Inc. -0.38
EVOK D Evoke Pharma, Inc. 8.26
TNDM B Tandem Diabetes Care, Inc. -0.54
GLMD C Galmed Pharmaceuticals Ltd. 1.67
CBAY F CymaBay Therapeutics Inc. -1.55
ZSAN F Zosano Pharma Corporation 3.36
ASND A Ascendis Pharma A/S 1.44
VKTX A Viking Therapeutics, Inc. 1.83
CLBS F Caladrius Biosciences, Inc. -3.23
VTVT F vTv Therapeutics Inc. 2.89
SYBX B Synlogic, Inc. 3.13
SBBP F Strongbridge Biopharma plc 1.44
MTP D Midatech Pharma PLC 0.54
SENS B Senseonics Holdings, Inc. -0.26
OTRK F Ontrak, Inc. 2.61
PETQ F PetIQ, Inc. -0.99
ZEAL C Zealand Pharma A/S 0.00
NMRD F Nemaura Medical Inc. 3.46
ORGS C Orgenesis Inc. 1.40
PRVB C Provention Bio, Inc. 3.41
NGM C NGM Biopharmaceuticals, Inc. -3.40
APLT F Applied Therapeutics, Inc. -0.70
OPT C Opthea Limited -3.19
HUMA A Humacyte, Inc. 0.63
RZLT F Rezolute, Inc. -8.27
SGTX B Sigilon Therapeutics, Inc. 0.49
GBS D GBS Inc. -4.29
GMVD F G Medical Innovations Holdings Ltd. -3.85
RANI D Rani Therapeutics Holdings, Inc. -3.40
View As Page of Charts


Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Recent Signals

Date Stock Signal Type
2021-09-17 ABT Fell Below 20 DMA Bearish
2021-09-17 ABT Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-09-17 ABT Bollinger Band Squeeze Range Contraction
2021-09-17 ALIM Jack-in-the-Box Bearish Bearish Swing Setup
2021-09-17 ALIM Narrow Range Bar Range Contraction
2021-09-17 ALKS Pocket Pivot Bullish Swing Setup
2021-09-17 ALKS Bollinger Band Squeeze Range Contraction
2021-09-17 ALKS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-09-17 ALKS Doji - Bullish? Reversal
2021-09-17 AMED Lower Bollinger Band Walk Weakness
2021-09-17 AMED Slingshot Bearish Bearish Swing Setup
2021-09-17 AMED Pocket Pivot Bullish Swing Setup
2021-09-17 AMED NR7-2 Range Contraction
2021-09-17 AMED NR7 Range Contraction
2021-09-17 AMED Narrow Range Bar Range Contraction
2021-09-17 AMPE Upper Bollinger Band Walk Strength
2021-09-17 AMPE Pocket Pivot Bullish Swing Setup
2021-09-17 AMPE 200 DMA Support Bullish
2021-09-17 APLT Narrow Range Bar Range Contraction
2021-09-17 APLT NR7 Range Contraction
2021-09-17 ARNA Pocket Pivot Bullish Swing Setup
2021-09-17 ARNA Stochastic Reached Overbought Strength
2021-09-17 ATHX Hammer Candlestick Bullish
2021-09-17 ATHX Lizard Bullish Bullish Day Trade Setup
2021-09-17 BDX New Uptrend Bullish
2021-09-17 BMY Pocket Pivot Bullish Swing Setup
2021-09-17 CBAY Spinning Top Other
2021-09-17 CBAY Fell Below 20 DMA Bearish
2021-09-17 CLBS 180 Bearish Setup Bearish Swing Setup
2021-09-17 CORT Volume Surge Other
2021-09-17 CORT Stochastic Buy Signal Bullish
2021-09-17 CORT Bollinger Band Squeeze Range Contraction
2021-09-17 DXCM MACD Bullish Signal Line Cross Bullish
2021-09-17 DXCM NR7 Range Contraction
2021-09-17 ENZ Crossed Above 20 DMA Bullish
2021-09-17 ESPR 1,2,3 Retracement Bearish Bearish Swing Setup
2021-09-17 ESPR Pocket Pivot Bullish Swing Setup
2021-09-17 ESPR Volume Surge Other
2021-09-17 ESPR 20 DMA Resistance Bearish
2021-09-17 ESPR Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-09-17 EVOK Crossed Above 20 DMA Bullish
2021-09-17 EVOK Crossed Above 50 DMA Bullish
2021-09-17 EVOK Bollinger Band Squeeze Range Contraction
2021-09-17 EVOK Expansion Pivot Buy Setup Bullish Swing Setup
2021-09-17 EVOK Pocket Pivot Bullish Swing Setup
2021-09-17 GBS Fell Below 20 DMA Bearish
2021-09-17 GBS 1,2,3 Pullback Bullish Bullish Swing Setup
2021-09-17 GBS Bollinger Band Squeeze Range Contraction
2021-09-17 GBS 50 DMA Resistance Bearish
2021-09-17 GLMD NR7 Range Contraction
2021-09-17 GLMD NR7-2 Range Contraction
2021-09-17 GMVD Stochastic Buy Signal Bullish
2021-09-17 GMVD Hammer Candlestick Bullish
2021-09-17 GMVD Calm After Storm Range Contraction
2021-09-17 HALO 50 DMA Support Bullish
2021-09-17 HALO Bollinger Band Squeeze Range Contraction
2021-09-17 HUMA MACD Bearish Signal Line Cross Bearish
2021-09-17 HUMA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-09-17 HUMA NR7 Range Contraction
2021-09-17 HUMA 1,2,3 Pullback Bullish Bullish Swing Setup
2021-09-17 ICPT Crossed Above 50 DMA Bullish
2021-09-17 IONS Pocket Pivot Bullish Swing Setup
2021-09-17 LLY NR7 Range Contraction
2021-09-17 LLY Narrow Range Bar Range Contraction
2021-09-17 LLY Calm After Storm Range Contraction
2021-09-17 LXRX Pocket Pivot Bullish Swing Setup
2021-09-17 MNKD NR7 Range Contraction
2021-09-17 MNKD Stochastic Reached Oversold Weakness
2021-09-17 MNKD Bollinger Band Squeeze Range Contraction
2021-09-17 MNKD Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-09-17 MRK New 52 Week Closing Low Bearish
2021-09-17 MRK Volume Surge Other
2021-09-17 MRK New 52 Week Low Weakness
2021-09-17 MRK Lower Bollinger Band Walk Weakness
2021-09-17 MTP Bollinger Band Squeeze Range Contraction
2021-09-17 MTP Doji - Bearish? Reversal
2021-09-17 MTP Crossed Above 50 DMA Bullish
2021-09-17 MTP 20 DMA Support Bullish
2021-09-17 NBIX Pocket Pivot Bullish Swing Setup
2021-09-17 NBIX 20 DMA Support Bullish
2021-09-17 NBIX Bollinger Band Squeeze Range Contraction
2021-09-17 NGM 20 DMA Support Bullish
2021-09-17 NGM Calm After Storm Range Contraction
2021-09-17 NGM Volume Surge Other
2021-09-17 NMRD Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-09-17 NMRD 20 DMA Support Bullish
2021-09-17 NURO 1,2,3 Pullback Bullish Bullish Swing Setup
2021-09-17 NVO Fell Below 20 DMA Bearish
2021-09-17 OCUP Upper Bollinger Band Walk Strength
2021-09-17 OCUP Stochastic Reached Overbought Strength
2021-09-17 OPT 50 DMA Support Bullish
2021-09-17 OPT Hammer Candlestick Bullish
2021-09-17 OPT Lizard Bullish Bullish Day Trade Setup
2021-09-17 ORGS Bollinger Band Squeeze Range Contraction
2021-09-17 ORGS Crossed Above 50 DMA Bullish
2021-09-17 PETQ Stochastic Reached Oversold Weakness
2021-09-17 PETQ NR7 Range Contraction
2021-09-17 PETS Lower Bollinger Band Walk Weakness
2021-09-17 PETS 180 Bearish Setup Bearish Swing Setup
2021-09-17 PETS Bollinger Band Squeeze Range Contraction
2021-09-17 PODD Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-09-17 PODD 50 DMA Support Bullish
2021-09-17 PODD Bullish Engulfing Bullish
2021-09-17 PODD Lower Bollinger Band Walk Weakness
2021-09-17 PRGO Cup with Handle Other
2021-09-17 PRGO Volume Surge Other
2021-09-17 PRGO 50 DMA Resistance Bearish
2021-09-17 PRGO Fell Below 200 DMA Bearish
2021-09-17 PRVB 50 DMA Support Bullish
2021-09-17 PRVB MACD Bullish Signal Line Cross Bullish
2021-09-17 PRVB Pocket Pivot Bullish Swing Setup
2021-09-17 PRVB 20 DMA Support Bullish
2021-09-17 PRVB Bollinger Band Squeeze Range Contraction
2021-09-17 RANI Fell Below 20 DMA Bearish
2021-09-17 RANI 1,2,3 Pullback Bullish Bullish Swing Setup
2021-09-17 RZLT MACD Bearish Signal Line Cross Bearish
2021-09-17 RZLT Volume Surge Other
2021-09-17 RZLT Stochastic Reached Oversold Weakness
2021-09-17 RZLT Expansion Breakdown Bearish Swing Setup
2021-09-17 SBBP Bullish Engulfing Bullish
2021-09-17 SENS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-09-17 SENS Bollinger Band Squeeze Range Contraction
2021-09-17 SENS Doji - Bullish? Reversal
2021-09-17 SENS Fell Below 20 DMA Bearish
2021-09-17 SENS NR7 Range Contraction
2021-09-17 SENS Narrow Range Bar Range Contraction
2021-09-17 SGTX Doji - Bearish? Reversal
2021-09-17 SGTX Volume Surge Other
2021-09-17 SGTX Shooting Star Candlestick Bearish
2021-09-17 SGTX Pocket Pivot Bullish Swing Setup
2021-09-17 TNDM Volume Surge Other
2021-09-17 TRIB 50 DMA Support Bullish
2021-09-17 TRIB Calm After Storm Range Contraction
2021-09-17 TRIB Bollinger Band Squeeze Range Contraction
2021-09-17 TRIB Stochastic Buy Signal Bullish
2021-09-17 VKTX Pocket Pivot Bullish Swing Setup
2021-09-17 VKTX Volume Surge Other
2021-09-17 VTVT Stochastic Buy Signal Bullish
2021-09-17 VTVT Bollinger Band Squeeze Range Contraction
2021-09-17 VTVT Pocket Pivot Bullish Swing Setup
2021-09-17 VTVT 20 DMA Resistance Bearish
2021-09-17 ZEAL Narrow Range Bar Range Contraction
2021-09-17 ZEAL Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-09-17 ZSAN Bollinger Band Squeeze Range Contraction
2021-09-17 ZSAN Pocket Pivot Bullish Swing Setup
2021-09-17 ZSAN 20 DMA Support Bullish
2021-09-17 ZSAN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup

Diabetes Stocks Recent News

Date Stock Title
Sep 18 MRK 10 Healthcare Stocks to Buy According to Mario Gabelli
Sep 18 BMY With Prothena Up Over 500% This Year, Is It Too Late to Get in?
Sep 18 MRK Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Death by One-Third Versus Chemotherapy With or Without Bevacizumab as First-Line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer
Sep 18 MRK Merck’s KEYTRUDA® (pembrolizumab) Demonstrated Superior Recurrence-Free Survival (RFS) in Patients With Resected High-Risk Stage II Melanoma Compared to Placebo in the Adjuvant Setting
Sep 18 BMY Nektar And Bristol Myers Squibb Expecting Bempeg Approval
Sep 17 MRK FDA advisory panel authorizes booster dose for those 65 & older
Sep 17 ENZ Enzo Biochem (ENZ) Investor Presentation - Slideshow
Sep 17 MRK FDA advisory panel votes against approving COVID-19 booster
Sep 17 MRK Wearing masks is something we should consider possibly in every flu, winter season: Doctor
Sep 17 MRK Impact of NYC’s Covid-19 vaccination proof mandate for restaurants
Sep 17 MRK Doctor: This conversation about boosters doesn’t take place just in the U.S.
Sep 17 ABT FDA Warns On Potential False Positive Results With Abbott's COVID-19 Tests
Sep 17 ABT FDA alerts healthcare providers on false positive potential with Abbott COVID tests
Sep 17 CORT Corcept Therapeutics' Relacorilant Combo Therapy Shows Clinical Benefit In Ovarian Cancer
Sep 17 ABT Podcast: How to Find Support When You're Studying STEM
Sep 17 LLY Lilly (LLY) Gets FDA Nod for Expanded Use of COVID Cocktail
Sep 17 NMRD Nemaura Medical announce Professor Osama Hamdy Joins their Advisory Board
Sep 17 BMY Gritstone Unveils "Off-The-Shelf" Neoantigen Immunotherapy Data In Lung Cancer
Sep 17 CORT Corcept Therapeutics shares fall 9% after results from mid-stage relacorilant ovarian cancer study
Sep 17 CORT Positive Results Presented at ESMO 2021 From Randomized, Controlled, Phase 2 Trial of Relacorilant in Patients with Recurrent Platinum-Resistant Ovarian Cancer

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

More about Diabetes
Browse All Tags